High materiality8/10
Revolution Medicines price target raised to $230 from $215 at Stifel Nicolaus
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Stifel Nicolaus raises RVMD target to $230 from $215; current price about $207.32. Signals bullish upside potential.
- Target raised to $230 from $215 by Stifel Nicolaus; current price $207.32.
Key facts
- 01
Target: $230
- 02
Posted price: $207.32
- 03
Analyst firm: Stifel Nicolaus
- 04
Analyst: Laura Prendergast
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.